Brief: Aravive Inc Says Entered Into Collaboration And License Agreement With 3D Medicines Inc On November 6

Aravive

10/11/2020 13:12

Nov 10 (Reuters) - Aravive Inc  ARAV.O :
    * ARAVIVE INC - ON NOVEMBER 6, ENTERED COLLABORATION AND
LICENSE
AGREEMENT WITH 3D MEDICINES INC.
    * ARAVIVE INC - GRANTED 3D MEDICINES EXCLUSIVE LICENSE TO
DEVELOP
AND COMMERCIALIZE PRODUCTS THAT CONTAIN AVB-500 AS SOLE DRUG
SUBSTANCE
    * ARAVIVE INC -  ELIGIBLE TO RECEIVE FROM 3D MEDICINE CASH
PAYMENTS OF $12 MILLION
    * ARAVIVE INC -  ELIGIBLE TO RECEIVE FROM 3D MEDICINE UP TO
$207
MILLION IN CLINICAL DEVELOPMENT, REGULATORY AND COMMERCIAL
MILESTONE PAYMENTS
    * ARAVIVE - 3D MEDICINES WILL BE SOLELY RESPONSIBLE FOR
DEVELOPMENT & COMMERCIALIZATION OF LICENSED PRODUCTS IN MAINLAND
CHINA, TAIWAN, HONG KONG & MACAU

Source: [ID: https://bit.ly/3eKaShk]
Further company coverage:  ARAV.O 

 ((Reuters.Briefs@thomsonreuters.com;))